About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

NCT00239109·7 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with a primary diagnosis of schizophrenia using the DSM-IV-TR criteria
Patient's clinical condition should justify treatment initiation with a new antipsychotic drug.

You may not be if

Patients at immediate risk of committing harm to self or others
Concurrent treatment with antipsychotic agents after randomization.

The record

StatusCompleted

PhasePhase 4

Taking part112

StartedApr 2003

UpdatedFeb 21, 2021

Conditions

Where7

Pfizer Investigational Site
Bilbao, Vizcaya, Spain
Pfizer Investigational Site
Badajoz, Spain
Pfizer Investigational Site
Barcelona, Spain